Cancer Patients Rate the Skin-Care Education They Receive, and Researchers Are Listening
A Yale research letter in the Archives of Dermatological Research examines how cancer patients judge the usefulness of educational content ...
Tag: Targeted therapy
After Nine Years of ALK Drugs, Lung Cancer Switches Gears—and a Second Mutation Saves the Day
A case report documents an ALK-rearranged lung cancer patient who acquired a druggable EGFR L858R mutation after nearly nine years ...
Folate-tipped nanoparticles offer a new route into stubborn brain tumors
A new review in Medical Oncology examines how folic acid-decorated nanoparticles could carry chemotherapy and imaging agents directly into glioblastoma ...
Three-minute mass spectrometry test maps brain tumor margins during surgery
Purdue and Mayo Clinic researchers showed that a three-minute syringe touch spray mass spectrometry method can distinguish glioma from healthy ...
Two Decades of Data Reveal How Small Molecule Drugs Reshaped Lung Cancer Treatment
A two-decade bibliometric analysis of nearly 5,000 studies maps how small molecule drug research transformed lung cancer therapy, revealing China's ...
Spinal Intradural Metastasis Emerges as a Late, Molecularly Distinct Stage of Cancer Spread
A Johns Hopkins study of 69 patients maps intradural spinal metastasis as a late stage of cancer spread, showing median ...
Silent Receptor Boost: Non-Signaling CARs Supercharge T-Cells Against Head and Neck Cancer
Researchers in Düsseldorf report that co-expressing a non-signaling EGFR-binding CAR alongside EGFRvIII-specific CAR T-cells enhances killing of head and neck ...
Real-World Data Show Zanubrutinib Delivers Strong Results in 410 Leukemia Patients
A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...
Cancer Drug Trametinib Shrinks Oral Tumors in Dogs, Trial Shows
A Cornell clinical trial found that the oral MEK inhibitor trametinib shrank or stabilized oral squamous cell carcinoma tumors in ...
How Lung Cancers Shed Their Identity to Outsmart KRAS Drugs
A new mouse study shows that lung adenocarcinomas can evade KRAS inhibitors by reprogramming their cellular identity through transcription factors ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!